Ibrutinib/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of ibrutinib and rituximab that may be used in the treatment of Waldenström macroglobulinemia and certain non-Hodgkin lymphomas (NHL), such as mantle cell lymphoma, and chronic lymphocytic leukemia/small lymphocytic lymphoma.

**Synonyms:** - Ibrutinib and Rituximab - Ibrutinib and Rituximab-abbs - Ibrutinib and Rituximab-arrx - Ibrutinib and Rituximab-blit - Ibrutinib and Rituximab-pvvr - Ibrutinib and Rituximab-rite - Ibrutinib and Rituximab-rixa - Ibrutinib and Rituximab-rixi - Ibrutinib-Rituximab - Ibrutinib/Rituximab - Imbruvica/Rituxan